[CIS PIDD] [cis-pidd] Evans Syndrome, iatrogenous CVID, granulomatous LIP

Markus Seidel markus.seidel at medunigraz.at
Wed Nov 6 16:43:35 EST 2013


Thanks! B12 and sFasL were normal.

Yours, Markus



Von: Nacho Gonzalez [mailto:nachgonzalez at gmail.com]
Gesendet: Mittwoch, 06. November 2013 22:26
An: CIS-PIDD
Betreff: Re: [cis-pidd] Evans Syndrome, iatrogenous CVID, granulomatous LIP



I´d try to be sure ALPS has been r/o: B12, sFASL ? (despite DNT borderline)

The best approach for GLILD was recently published JCI Jan (AZP + RTX better
than one alone) http://www.ncbi.nlm.nih.gov/pubmed/22930256



We have tried in one patient (AZP and RTX) and worked. In other, RTX alone
improved GLILD for several years.



Hope this helps,



Luis Ignacio Gonzalez-Granado

Immunodeficiencies.

Hematology. Oncology

Hospital 12 octubre.

Madrid. Spain





2013/11/6 Markus Seidel <markus.seidel at medunigraz.at>

Dear Colleagues,

what would be your suggestions in the therapeutic dilemma in a young adult
who

has been treated successfully with MMF for 5 years for Evans Syndrome, under
that time had a CVID-like B-cell phenotype (<100/µL B cells, absence of csmB
cells, IgG2 and IgA-def.), did not require Ig-substitution, no severe
infections,

initially had severe pancytopenia, autoimmune hemolytic anemia,

who then developed granulomatous lymphocytic interstitial pneumonitis early
this year (LIP, either as consequence of iatrogenous CVID or occupational
dust exposure; no infectious agent identified)

and when IS was terminated, had recurrence of severe thrombocytopenia
(<10.000/µL), neutropenia (600-900/µL), autoantibodies against neutrophils,
platelets, pos. Coombs test, but recovered clinically from LIP, which now
appears to be stable in Chest CT.

his mother suffered from granulomatosis with polyangiitis (GPA) – but no
other than blood-cell tissue- or nuclear autoantibodies are detectable in
the patient.



I fear that rituximab or other systemic IS would exacerbate his LIP, which
has been stable for 4 months now under rapamycin (the latter did not improve
his thrombocytopenia, though); the B cells recovered to >200/µL and >2% csmB
cells after discontinuation of MMF, but are now lower again under rapamycin,
DNT cells borderline increased 3-5% of CD3;

Romiplostim works short time (1-2 weeks), but doesn’t look like a very good
long term option;

Splenectomy?, Danazole?, AZT?

...SCT?



Thanks for your comments or thoughts,

Sincerely,

Markus Seidel





Markus G. Seidel, M.D., Assoc.Prof.

Consultant| Dept.of Pediatric Hematology-Oncology | Univ.Clinics of
Pediatric and Adolescent Medicine | Medical University Graz | Auenbruggerpl.
34/2 | A-8036 Graz | Austria | T. 0043 316 385 80215
<tel:0043%20316%20385%2080215> | F. 0043 316 385 13717
<tel:0043%20316%20385%2013717> | Secr. 0043 316 385 13485
<tel:0043%20316%20385%2013485> |

Coordinator of the Working Group for Pediatric Immunology of the Austrian
Society of Pediatrics and Adolescent Medicine



_____

Attention:
This e-mail and any attachment is for authorised use by the intended
recipient(s) only. It may contain proprietary, confidential and/or
privileged information and should not be copied, disclosed, distributed,
retained or used by any other party. If you are not an intended recipient
please notify the sender immediately and delete this e-mail (including
attachments and copies).







---

The CIS-PIDD listserv is supported by:


The science & practice of human immunology

P: +1.414.224.8095 <tel:%2B1.414.224.8095>
E: info at clinimmsoc.org

Not a member of CIS? Please visit www.clinimmsoc.org
<https://cis.execinc.com/edibo/Signup> to join!

You are currently subscribed to cis-pidd as: nachgonzalez at gmail.com.
To unsubscribe click here:
http://lm.clinimmsoc.org/u?id=183824481.b83ee7e83de457b4848325aafc56219c
<http://lm.clinimmsoc.org/u?id=183824481.b83ee7e83de457b4848325aafc56219c&n=
T&l=cis-pidd&o=44083062> &n=T&l=cis-pidd&o=44083062



---

The CIS-PIDD listserv is supported by:

<http://www.clinimmsoc.org/UserFiles/image/cis-pidd-list-logo_v1.jpg>
The science & practice of human immunology

P: +1.414.224.8095
E: info at clinimmsoc.org

Not a member of CIS? Please visit www.clinimmsoc.org
<https://cis.execinc.com/edibo/Signup> to join!

You are currently subscribed to cis-pidd as: markus.seidel at medunigraz.at.
To unsubscribe click here:
http://lm.clinimmsoc.org/u?id=194546399.69f6a3a52bee7cbbad0ed5b65e925d2f
<http://lm.clinimmsoc.org/u?id=194546399.69f6a3a52bee7cbbad0ed5b65e925d2f&n=
T&l=cis-pidd&o=44083211> &n=T&l=cis-pidd&o=44083211


---
The CIS-PIDD listserv is supported by the Clinical Immunology Society
The science & practice of human immunology

P: +1.414.224.8095
E: info at clinimmsoc.org

Not a member of CIS? Please visit www.clinimmsoc.org to join!

You are currently subscribed to cis-pidd as: pagid at list.clinimmsoc.org.
To unsubscribe click here: http://lm.clinimmsoc.org/u?id=183939985.3ea13d40a15475ac00ebbd9cd8a37d6d&n=T&l=cis-pidd&o=44083271
or send a blank email to leave-44083271-183939985.3ea13d40a15475ac00ebbd9cd8a37d6d at lists.clinimmsoc.org
-------------- next part --------------
An HTML attachment was scrubbed...
URL: <http://seven.pairlist.net/pipermail/pagid/attachments/20131106/c756ba8a/attachment.html>


More information about the PAGID mailing list